Barely Significant
← all excerpts

Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma.

J Immunother Cancer · 2014 · PMC4072479 · PMID 24971166

Europe PMCDOI
1
hedged sentence
0.1400
closest p · 2.8× alpha
0.1400
boldest claim

The sentences

did not reach statistical significanceP = 0.14not close (p > 0.1)
A randomized study of recombinant GM-CSF (125 μg/m 2 daily for 14 consecutive days in 28-day cycles) versus placebo in patients with completely resected stage IIIB/IIIC/IV or mucosal melanoma, there was a trend toward improvement in DFS although it did not reach statistical significance (11.5 vs 9.2 months; HR, 0.88; P = 0.14), and no improvement in overall survival (OS; 69.6 vs 62.4 months; HR, 0.96; P = 0.78) [ 40 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.